STAT+: Top U.S. officials pressured Germany to pay more for prescription drugs
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- U.S. Trade Representative Jamieson Greer met with German Ambassador Jens Hanefeld and health adviser Chris Klomp at a breakfast to discuss drug pricing.
- Trump administration is using a broader strategy to pressure foreign markets to pay more for medicines while the U.S. seeks lower domestic costs.
- Section 301 tariffs were floated as a possible lever, giving the U.S. authority to address “unfair” trade practices in drug pricing.
- German Ambassador Jens Hanefeld said he would take the proposal back to Berlin for review, but no immediate agreement was reached.
Why it matters: U.S. drug manufacturers stand to benefit, while German patients will face higher out‑of‑pocket costs, and the move adds pressure on trans‑Atlantic trade relations as Washington seeks to shift cost burdens abroad.
Ask SkimNews
